Kazuo Miyazaki

Kazuo Miyazaki

Speaker
Founder & CEO – MiCAN Technologies Inc.

2016 – Present President & Chief Executive Officer , MICAN TECHNOLOGIES INC., Kyoto, Japan
・ released SARS-Cov-2 virus research cell by gene modified human dendritic cell from iPS cell.
・  Managing and researching the project to provide iPS derived immature dendritic cell (iMylc cell) for  virus research and P.vivax cultivation tools for Malaria scientists using (test product stage)
・Established MiCAN Technologies (biotechnology start up company) to progress the project.
2014 – 2017    Senior Researcher,  ASUBIO PHARMA CORPORATION, Kobe, Japan
・  Researched new drug candidates of neuroscience disease.
2013 – 2014   Group Leader , DAIICHI SANKYO LIFE SCIENCE RESEARCH CENTRE INDIA,
・ Researched new anti-infectious drug (Gram negative, antibiotic-resistant).
2010 – 2013   Senior Researcher, Medicinal Chemistry Department, ASUBIO PHARMA CORPORATION, Kobe, Japan
2007 – 2010    Researcher, Medicinal Chemistry Department, ASUBIO PHARMA CORPORATION.
2005 – 2007    Researcher, Medicinal Chemistry Department, Daiichi Asubio Pharma Co., Ltd.
2003 – 2005    Researcher, Daiichi Suntory Biomedical Institute Co., Ltd.
1998 – 2003    Associate Researcher, Medicinal Chemistry Department, Suntory Biomedical Institute , Suntory Ltd.

Learn
Articles